Loading presentation...

Present Remotely

Send the link below via email or IM


Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.


Pediatric Pertussis

No description

Christine Tafoya

on 19 April 2011

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Pediatric Pertussis

Case Study
A 5-month-old boy was admitted to the hospital with severe cough.
Symptoms began about two weeks earlier with the onset of upper respiratory tract congestion and a milder cough.
Primary provider had assessed him at this time, did no tests and prescribed symptomatic treatment.
The cough worsened to the point of causing some post-tussive emesis and brief loss of breath with cyanosis.
Past Medical History
Pre/post natal history unremarkable
No history of conjuctivitis
Otherwise healthy infant with no past history of illness or surgery
No allergies
No medicines except the over-the-counter decongestant given during his first visit
No immunizations
18-year-old mother has had a coughing illness for several weeks. Examination
Temperature: 37.9°C
Pulse, Respiratory Rate, and Oxygen levels within normal limits
Marked upper airway congestion
Breath sounds revealed moist, bilateral rhonchi with minimal wheezing
Began coughing, > 30 seconds
Mild cyanosis Tests
WBC: 34,000 with 85% lymphocytes
Chest X-ray: non-specific, diffuse bilateral perihilar pattern
Rapid strep test: negative
Rapid influenza antigen test: negative
Rapid RSV: negative
Nasopharyngeal swab: pending (7-10 days)
Polymerase Chain Reaction: pending (1-2 days)
Blood cultures: pending (3 days) Pediatric Pertussis
"Whooping Cough"
by Christine Tafoya Etiology
"Bordetella pertussis"
-very small gram-negative rod, looks similar to a coccobacillus
filamentous hemagglutinin (FHA) Pathogenesis
-Toxin-mediated disease
-The bacteria attach to cilia of the respiratory tract, and produce toxins which paralyze the cilia, leading to respiratory tract inflammation
-This inflammation makes it very difficult for the child to “clear” their pulmonary secretions Stage 1: Catarrhal
-From word, “catarrh”, meaning inflammation of the mucous membranes, especially in the nose and throat
-Begins gradually, initially presenting as a minor respiratory tract infection
-Lasts 1 to 2 weeks
-Characterized by:
•Coryza (runny nose)
•Low-grade fever
•Mild, occasional cough (which gradually becomes more severe)
Stage 2: Paroxysmal
-From word, “paroxysm”, meaning a sudden attack, recurrence, or intensification of a disease .
-Usually lasts 1-6 weeks, but can last up to 10 weeks
-Intermittent cough becomes paroxysmal, terminating with inspiratory whoop followed by posttussive vomiting.
-The violent coughing spasms can result in bursting of blood vessels in the eyes, vomiting, and rarely, seizures due to hemorrhages in the brain.
-Cyanosis (during an attack): the skin appears blue/purple due to decreased oxygen (hypoxia)- also seen in chronic bronchitis (“blue bloaters”) Paroxysmal attacks:
-Frequently at night
-Average: 15 attacks/24 hours.
-Increase in frequency during the first 1-2 weeks
-Remain at the same frequency for 2-3 weeks
-Gradual decrease Stage 3: Convalescent phase:
-Convalescence: gradual recovery of health and strength after an illness
-Usually lasts 7 to 10 days, but can range from 4 to 21 days.
-Less persistent, paroxysmal coughs
-Paroxysms often recur with subsequent respiratory infections for many months Risk Factors
-Anyone who has not been previously immunized
-Adolescents and adults who received the vaccine as children, but have not been re-vaccinated
-Babies 6 months and under Transmission and Epidemiology
-Transmitted via respiratory droplets.
-Highly contagious during catarrhal and paroxysmal stages.
-Most infants are infected by older siblings, parents, or caregivers, who do not know they have the disease.
-About 25% of infections occur in older children and adults
-Results in 300,000-500,000 deaths annually worldwide
Recent Outbreaks
-2010: 9477 cases in California, including 10 infant deaths
-2010: 1519 cases in Michigan
-2010: 964 cases in Ohio
-Arizona reports an average of 200-300 cases each year Complications
-Serious and sometimes life-threatening complications in infants and young children
-In infants younger than 1 year of age who get pertussis, more than half must be hospitalized.
Of those hospitalized:
•1 in 5 get pneumonia
•1 in 100 will have convulsions
•Half will have apnea
•1 in 300 will have encephalopathy
•1 in 100 will die Diagnostics
-Distinctive clinical symptoms
-Cultures: Typically a pertussis culture and PCR test will both be ordered, as early in the illness as possible.
-Can take 2-3 weeks for a culture to grow. Treatment
Mainly supportive care:
-Admission to the hospital
-Intravenous (IV) fluids
-Breathing support from a ventilator
-Prevention of secondary infections
-Antibiotics (azithromycin, erythromycin, clarithromycin, trimethoprim-sulfamexazole)
-Possible steroids
-Beta2-agonists Vaccination is the best way to prevent Pertussis .
-Infants/Children: protects children against 3 diseases: diphtheria, tetanus, and pertussis. For maximum protection against pertussis, children need 5 DTaP shots.
-Preteens: 11 or 12 years should get a dose of Tdap, a booster for tetanus, diphtheria, and pertussis.
-Parents to be and those around infants: Tdap
-If an outbreak of Pertussis in the community occurs, there is a chance that a fully vaccinated person may contract the disease Differential Diagnosis for
"whoop-like cough"

A. Bordetella pertussis
B. Chlamydia trachomatis
C. Adenovirus
D. Bordetella parapertussis
Brady, M. (2009). Pertussis. In C. Burns, A. Dunn, M. Brady, N. Barber Starr, & C. Blosser, Pediatric Primary
Care (pp. 778-779). Saunders Elsevier: St. Louis.
Cowan, M., & Talaro, K. (2006). Microbiology: A Systems Approach. New York: McGraw-Hill.
Infectious Disease Epidemiology Program. (n.d.). Retrieved April 8, 2011, from Arizona Department of Health and Human Services: http://www.azdhs.gov/phs/oids/epi/disease/pert/pertussis_g.htm
Jassim, H. (n.d.). Bordetella pertussis. Retrieved April 10, 2011, from
Pertussis (Whooping Cough). (n.d.). Retrieved April 9, 2011, from Centers for Disease Control and
Prevention: http://www.cdc.gov/pertussis/index.html
Pertussis: The Test. (n.d.). Retrieved April 9 2011, from Lab Tests Online:
Ratnapalan, S., Parkin, P., & Allen, U. (2005, April). Case 1: The deadly danger of pertussis. Paediatrics &
Child Health, 10(4), 221-222.
Schoenstadt, A. (n.d.). Whooping Cough Treatment. Retrieved April 9, 2011, from eMedTV:
Whooping Cough Risk Factors. (n.d.). Retrieved April 9, 2011, from Mayo Clinic:
Whooping Cough: Management and Diagnosis of Pertussis. (2011, March). Pediatric Emergency
Medicine Reports: PEMR. Retrieved April 10, 2011, from ProQuest Health and Medical Complete. (Document ID: 2297496471). Normal CXR
Full transcript